Introduction Low‐ and middle-income countries (LMICs) suffer the highest rates of death and disability due to emergency ...
Q3 2025 Management View CEO Joseph Payne reported that interim Phase II data for ARCT-032, the company’s mRNA therapeutic candidate for cystic fibrosis (CF), showed "treatment with inhaled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback